| mitogen activated protein kinase 14 |
SULCONAZOLE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
SULCONAZOLE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
DANAZOL |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
DANAZOL |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, alpha |
DIETHYLSTILBESTROL |
Chemokine CXCR1(IL-8A) |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
CEFOTAXIME |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
CEFOTAXIME |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor, beta 2 |
DESLORATADINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
CYCLOHEXIMIDE |
Neuropeptide Y1 |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
CYCLOHEXIMIDE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
CYCLOHEXIMIDE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
CYCLOHEXIMIDE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 beta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, delta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type X, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage gated, type VIII, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
Y-27632 |
CYP450-3A4 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
Y-27632 |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 beta |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, delta |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type X, alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage gated, type VIII, alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
CIPROFIBRATE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
PREDNISONE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
PREDNISONE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor, beta 2 |
ECONAZOLE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor B2 |
ECONAZOLE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3a |
ECONAZOLE |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3b |
ECONAZOLE |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
ECONAZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
ECONAZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
MICONAZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
MICONAZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| cysteinyl leukotriene receptor 1 |
METHOXSALEN |
Leukotriene D4 |
-20% |
NoneNone |
NoneNone |
View
|
| cysteinyl leukotriene receptor 1 |
METHOXSALEN |
Leukotriene D4 |
-20% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
DEXIBUPROFEN |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
(+)-THALIDOMIDE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
(+)-THALIDOMIDE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
PIMARICIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
PIMARICIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
PIMARICIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
VECURONIUM BROMIDE |
Adrenergic alpha2B |
-20% |
NoneNone |
NoneNone |
View
|
| interleukin 1 receptor, type I |
VECURONIUM BROMIDE |
Interleukin IL-1 alpha |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
BENZYL ALCOHOL |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
PIMARICIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
INDOMETHACIN |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
INDOMETHACIN |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
| DNA encoding receptor of vasoactive intestinal polypeptide |
INDOMETHACIN |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
| adenosine A2a receptor |
FLUOROURACIL |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
OUABAIN |
Adenosine A3 |
-20% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
PIMARICIN |
Histamine H2 |
-20% |
NoneNone |
NoneNone |
View
|
| adenosine A2a receptor |
KETOCONAZOLE |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
KETOCONAZOLE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
KETOCONAZOLE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
CHLOROXYLENOL |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
DEXFENFLURAMINE |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
KETOCONAZOLE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
KETOCONAZOLE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
KETOCONAZOLE |
Aldose Reductase |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
AZATHIOPRINE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
AZATHIOPRINE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
CYCLOHEXIMIDE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
CYCLOHEXIMIDE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
CYCLOHEXIMIDE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
CYCLOHEXIMIDE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
CYCLOHEXIMIDE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| amiloride-sensitive cation channel 5, intestinal |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
OFLOXACIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
MEVASTATIN |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
CYCLOHEXIMIDE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
CYCLOHEXIMIDE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
PREDNISOLONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
PREDNISOLONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
ACETAZOLAMIDE |
Dopamine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
BUDESONIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
BUDESONIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
ALBENDAZOLE |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
BUDESONIDE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
TOBRAMYCIN |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
TOBRAMYCIN |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
ENOXACIN |
Adrenergic alpha2A |
-20% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 4 |
TYRPHOSTIN A23 |
Chemokine CCR4 |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
CYCLOPHOSPHAMIDE |
Adrenergic alpha2A |
-20% |
NoneNone |
NoneNone |
View
|
| epidermal growth factor receptor |
TOBRAMYCIN |
Protein Tyrosine Kinase, EGF Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
TYRPHOSTIN A23 |
Adrenergic, Norepinephrine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
OFLOXACIN |
Adrenergic, Norepinephrine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
OFLOXACIN |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
OFLOXACIN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
OFLOXACIN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
ALPHA-TOCOPHEROL |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
ALPHA-TOCOPHEROL |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
CYCLOHEXIMIDE |
Adenosine A3 |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
PREDNISOLONE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
PREDNISOLONE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
ENOXACIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ENOXACIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
ENOXACIN |
Adenosine A3 |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 5a, mitochondrial |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 3 |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 2 |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 4 |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase XI |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase IX |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase VIII |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase VII |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase VA, mitochondrial |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase IV |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase III, muscle specific |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase I |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase XIV |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase VB, mitochondrial |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase XII |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase VI |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase II |
TYRPHOSTIN A23 |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
AZATHIOPRINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
AZATHIOPRINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
AZATHIOPRINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
AZATHIOPRINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
METYRAPONE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
METYRAPONE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
METYRAPONE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
METYRAPONE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|